Orbimed Advisors Llc - Jun 28, 2024 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
10%+ Owner
Signature
/s/ Carl L. Gordon, Member of OrbiMed Advisors LLC
Stock symbol
TELA
Transactions as of
Jun 28, 2024
Transactions value $
-$2,022,000
Form type
4
Date filed
7/2/2024, 04:54 PM
Previous filing
Jun 20, 2024
Next filing
Jul 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Sale -$1.79M -378K -13.33% $4.74 2.46M Jun 28, 2024 See footnotes F1, F2
transaction TELA Common Stock Sale -$64.1K -13.7K -0.56% $4.68 2.44M Jul 1, 2024 See footnotes F1, F2
transaction TELA Common Stock Sale -$166K -36.6K -1.5% $4.54 2.41M Jul 2, 2024 See footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Orbimed Advisors Llc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These securities are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP IV. By virtue of such relationships, OrbiMed Advisors and GP IV may be deemed to have voting power and investment power over the securities held by OPI IV and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OPI IV.
F2 Each of OrbiMed Advisors and GP IV disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Persons, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.